Purpose of the Test
- Determine tumor response to immunotherapies (PD-1/PD-L1)
- Screen for Lynch syndrome, a hereditary colon cancer risk
- Provide prognostic information regarding disease progression
Book MSI Testing in Saudi Arabia | Lahalak Medical Platform
MSI testing helps determine response to modern immunotherapies and early detection of Lynch syndrome, ensuring a precise, personalized treatment plan for your health to achieve the best possible outcomes.
Scientific name: Microsatellite Instability (MSI) Testing
An advanced molecular analysis performed on tumor tissue to evaluate genetic changes in microsatellites. It identifies patient eligibility for immunotherapy and diagnoses hereditary cancer predispositions like Lynch syndrome.
Service type
Molecular Oncology Test
Duration
7-10 working days
Fasting
Fasting is not required
Included Services
- Tissue or blood sample analysis
- Detailed molecular genetic report
- Medical recommendations for immunotherapy
Medical Service Information
Target Groups
- Patients diagnosed with colorectal cancer
- Individuals with a strong family history of cancer
- Patients being considered for modern immunotherapy
Understanding Results
- MSI-High: Indicates a high likelihood of response to immunotherapy
- MSS: Indicates microsatellite stability, usually not requiring immunotherapy
- Results guide the oncologist in selecting the most effective treatment protocol
Conditions & Notices
- Provide a tumor sample (paraffin block) or blood sample as required
- Bring previous medical reports and biopsy results
Medical services you might also like
